EQS-Adhoc: Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
Ladenburg, Germany, 12 March 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech Company developing innovative Antibody Drug Conjugates (ADCs), and HealthCare Royalty (HCRx) today ...
Psoriatic Arthritis Market Sees Major Shift With Growing Biosimilar Adoption Delveinsight
The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbus ...